ASPELONE Liquid Ref.[51207] Active ingredients: Prednisolone

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2022  Publisher: PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

Product name and form

ASPELONE 15 mg per 5 ml liquid.

Pharmaceutical Form

Liquid.

ASPELONE is a clear, pinkish-red liquid, free from foreign particles with a sweet raspberry odour.

Qualitative and quantitative composition

Each 5 ml liquid of ASPELONE contains prednisolone sodium phosphate equivalent to 15 mg prednisolone base.

Preservatives:

Sodium methyl parahydroxybenzoate 0,21% m/v

Sodium propyl parahydroxybenzoate 0,022% m/v

Contains sugar: Sorbitol liquid (70%) 2,5 g/5 ml, glycerol 0,5 g/5ml.

Contains sweetener: Saccharin sodium 7,5 mg/5 ml.

For full list of excipients, see section 6.1.

Active Ingredient Description
Prednisolone

Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.

List of Excipients

Colour raspberry red (C.I.14720)
Dipotassium hydrogen phosphate (for pH adjustment)
Disodium edetate
Flavour raspberry
Glycerol
Potassium dihydrogen phosphate (for pH adjustment)
Propylene glycol
Purified water
Saccharin sodium
Sodium chloride
Sodium methyl parahydroxybenzoate
Sodium propyl parahydroxybenzoate
Sorbitol liquid

Pack sizes and marketing

100 ml is packed in a round amber glass bottle sealed with a white, tamper evident, expanded polyethylene lined polypropylene screw cap. The bottle is placed in a cardboard unit carton with a leaflet.

50 ml is packed in a round amber glass bottle sealed with a white, tamper evident, expanded polyethylene lined polypropylene screw cap. The bottle is placed in a cardboard unit carton with a leaflet.

Not all pack sizes may be marketed.

Marketing authorization holder

PHARMACARE LIMITED, Healthcare Park, Woodlands Drive, Woodmead 2191

Marketing authorization dates and numbers

41/21.5.1/0189

Date of first authorization: 19 March 2010

Drugs

Drug Countries
ASPELONE South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.